HopeStage
Back to all studies
RecruitingNCT07173205

A coping and emotional support toolkit for young cancer survivors

About this titleRead the official source — NCT07173205
Behavioural studyAges 15–39United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 15 years to 39 years.

What will I do during this study?

This recruiting study is testing ASCENT, a digital toolkit to help adolescent and young adult cancer survivors manage depressive symptoms. The toolkit includes psychoeducation and components based on evidence-based depression interventions. Participants aged 15–39 who completed cancer treatment within the past five years use a smartphone and are assigned to different combinations of toolkit components. People with severe or persistent mental illness or severe suicidal thoughts involving a plan or intent are excluded.

Listed locations
Greenville and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
208
Sponsor
East Carolina University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
From 15 Years to 39 Years
Official registry ID
NCT07173205
Official title
Show the full official title

R00 Full Factorial Trial: Optimizing ASCENT

Recruitment & locations

Currently recruiting

Greenville · Winston-Salem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is East Carolina University, a university.

Who can participate?

Listed age limits: 15 years to 39 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies